Insulin glargine/lixisenatide fixed‐ratio combination ( iGlarLixi ) compared with premix or addition of meal‐time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta‐analysis-Reference-Cited by-同舟云学术

Insulin glargine/lixisenatide fixed‐ratio combination ( iGlarLixi ) compared with premix or addition of meal‐time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta‐analysis

Published:2020-09-03 Issue:11 Volume:22 Page:2179-2188
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Home Philip¹^ORCID,Blonde Lawrence²^ORCID,Kalra Sanjay³,Ji Linong⁴^ORCID,Guyot Patricia⁵,Brulle‐Wohlhueter Claire⁶,Murray Erin⁷,Shah Roshan⁷,Sayre Toby⁷,Shaunik Alka⁵

Affiliation:

1. Translational and Clinical Research Institute Newcastle University Newcastle upon Tyne UK

2. Ochsner Diabetes Clinical Research Unit, Frank Riddick Diabetes Institute, Department of Endocrinology Ochsner Medical Center New Orleans Louisiana USA

3. Department of Endocrinology Bharti Hospital Karnal India

4. Peking University People's Hospital Beijing China

5. Global Medical Affairs Sanofi Bridgewater New Jersey USA

6. Global Medical Affairs Sanofi Paris France

7. Doctor Evidence Santa Monica California USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14148

Reference46 articles.

1. A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes

2. The Treat-to-Target Trial

3. Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients

4. Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA

5. National Institute for Health and Care Excellence. Type 2 diabetes in adults: management (NICE Guideline 28). 2015.https://www.nice.org.uk/guidance/ng28. Accessed April 22 2019.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification;Diabetes Therapy;2024-06-27

2. iGlarLixi for type 2 diabetes: a systematic review and meta-analysis;Endocrine;2024-05-13

3. Therapy of Type 2 Diabetes;Experimental and Clinical Endocrinology & Diabetes;2024-04-10

4. Therapie des Typ-2-Diabetes;Die Diabetologie;2024-01-30

5. Advancing therapy in people with suboptimally controlled basal insulin‐treated type 2 diabetes: Subanalysis of the SoliMix trial in participants in Latin American countries;Diabetes, Obesity and Metabolism;2023-05-30